In 2000, a group of neurologists and neuroscientists at the University of Michigan Medical School came together to form what is now known as the Program for Neurology Research & Discovery (PNR&D). Eva L. Feldman, M.D., Ph.D., F.A.N.A., F.A.A.N., Russell N. DeJong Professor of Neurology, directs the group’s 30-plus scientists, clinicians and students, who are working toward the common goal of understanding and curing neurological diseases.
Program for Neurology Research & Discovery Goals:
- Advance the understanding of the causes of neurological diseases
- Develop new treatment options for patients
- Provide information to the community about the role that basic scientific research plays in the understanding of disease and development of new treatments
Neurological diseases are life-altering conditions resulting from the deterioration of the nervous system. Many people are familiar with the devastating deterioration caused by neurological diseases like ALS (Lou Gehrig’s disease) and Alzheimer’s disease. This same deterioration also affects patients with diabetes (complications including diabetic neuropathy and retinopathy), traumatic injury to the nervous system, pediatric neuromuscular diseases, stroke, epilepsy, and multiple sclerosis. Patients with neurological diseases have very few treatment options and no cures available to them. With a combination of scientific expertise, clinical experience, and technical resources found in few other places, PNR&D research has already led to clinical trials for new treatments, and it has advanced the understanding of how and why neurological diseases develop.